CS Diagnostic Corp. is a global healthcare innovation company committed to advancing medical diagnostics through innovation and precision technology. With a strong foundation in research and a global ...

CHEYENNE, Wyo., Feb. 11, 2026 (GLOBE NEWSWIRE) -- CS Diagnostics Corp. (OTCQB: CSDX) (“CS Group” or the “Company”), a medical technology and hygiene solutions company, today announced the appointment ...

Short interest for CS Diagnostics gives investors a sense of the degree to which investors are betting on the decline of CS Diagnostics's stock. Short interest data is updated every two weeks.

CHEYENNE, WY / ACCESS Newswire / April 15, 2025 / Neuss, Germany: CS Diagnostics Corp. (CSDX) is pleased to announce that it has received a Letter of Intent from SAN ART CAPITAL SAS, a leading ...

NEUSS, GERMANY AND CHEYENNE, WY / ACCESS Newswire / July 16, 2025 / CS Diagnostics Corp. (CSDX) is pleased to announce that it has successfully submitted the final draft of Form F-10 registration ...

CS Diagnostics Corp. (OTCQB: CSDX) (or “the company”) is delighted to announce the U.S. launch of MEDUSA, alongside its product CS Protect-Hydrogel. MEDUSA is a next-generation smart disinfectant ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

CHEYENNE, WYOMING / ACCESS Newswire / September 8, 2025 / CS Diagnostics Corp. (OTCQB:CSDX) is delighted to announce the submission of its CS-Protect Hydrogel patenting process application as a ...

CHEYENNE, WY AND NEUSS, GERMANY / ACCESS Newswire / July 1, 2025 / CS Group announced that its regional subsidiary, CS Interpharm General Trading CO. LLC has signed a Memorandum of Understanding (MOU) ...